Terms: = Lung cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Treatment
91 results:
1. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
[TBL] [Abstract] [Full Text] [Related]
2. The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment.
Liu LZ; Wang B; Zhang R; Wu Z; Huang Y; Zhang X; Zhou J; Yi J; Shen J; Li MY; Dong M
Cell Death Dis; 2023 Aug; 14(8):548. PubMed ID: 37612265
[TBL] [Abstract] [Full Text] [Related]
3. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
4. CLIC4 Regulates Endothelial Barrier Control by Mediating PAR1 Signaling via RhoA.
Kleinjan ML; Mao Y; Naiche LA; Joshi JC; Gupta A; Jesse JJ; Shaye DD; Mehta D; Kitajewski J
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1441-1454. PubMed ID: 37317855
[TBL] [Abstract] [Full Text] [Related]
5. Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review.
Gomes AR; Varela CL; Pires AS; Tavares-da-Silva EJ; Roleira FMF
Bioorg Chem; 2023 Sep; 138():106600. PubMed ID: 37209561
[TBL] [Abstract] [Full Text] [Related]
6. Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer.
Xu Y; Yan J; Zhou C; Wu L; Wang H; Zhao J; Zhou M; Wang J; Zheng X; Zhang L; Jiang K; Zheng X; Miao Q; Wu S; Zou Z; Lian R; He Y; Chen R; Yang S; Li Y; Chen S; Lin G
Eur J Cancer; 2023 Jul; 188():81-89. PubMed ID: 37201385
[TBL] [Abstract] [Full Text] [Related]
7. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract] [Full Text] [Related]
8. Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I; Pastorino L; Tanda ET; Andreotti V; Dalmasso B; Solari N; Mascherini M; Cabiddu F; Guadagno A; Coco S; Allavena E; Bruno W; Pietra G; Croce M; Gangemi R; Piana M; Zoppoli G; Ferrando L; Spagnolo F; Queirolo P; Ghiorzo P
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901733
[TBL] [Abstract] [Full Text] [Related]
9. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell lung cancer.
Liao X; Cai R; Li G; Chen F
Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
[TBL] [Abstract] [Full Text] [Related]
10. CircSRSF4 Enhances Proliferation, Invasion, and Migration to Promote the Progression of Osteosarcoma via rac1.
Sun X; Zhao X; Xu S; Zhou Y; Jia Z; Li Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682879
[TBL] [Abstract] [Full Text] [Related]
11. FMRP ligand circZNF609 destabilizes rac1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
[TBL] [Abstract] [Full Text] [Related]
12. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Al-Samkari H; Kolb-Sielecki J; Safina SZ; Xue X; Jamieson BD
Lancet Haematol; 2022 Mar; 9(3):e179-e189. PubMed ID: 35240074
[TBL] [Abstract] [Full Text] [Related]
13. Functional Analysis of MET Exon 14 Skipping Alteration in cancer Invasion and Metastatic Dissemination.
Wang F; Liu Y; Qiu W; Shum E; Feng M; Zhao D; Zheng D; Borczuk A; Cheng H; Halmos B
Cancer Res; 2022 Apr; 82(7):1365-1379. PubMed ID: 35078819
[TBL] [Abstract] [Full Text] [Related]
14. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in cancer.
Celus W; Oliveira AI; Rivis S; Van Acker HH; Landeloos E; Serneels J; Cafarello ST; Van Herck Y; Mastrantonio R; Köhler A; Garg AD; Flamand V; Tamagnone L; Marine JC; Di Matteo M; Costa BM; Bechter O; Mazzone M
Cancer Immunol Res; 2022 Jan; 10(1):126-141. PubMed ID: 34815265
[TBL] [Abstract] [Full Text] [Related]
15. TIAM1-rac1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.
Payapilly A; Guilbert R; Descamps T; White G; Magee P; Zhou C; Kerr A; Simpson KL; Blackhall F; Dive C; Malliri A
Cell Rep; 2021 Nov; 37(6):109979. PubMed ID: 34758330
[TBL] [Abstract] [Full Text] [Related]
16. Optimizing metastatic-cascade-dependent rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging.
Floerchinger A; Murphy KJ; Latham SL; Warren SC; McCulloch AT; Lee YK; Stoehr J; Mélénec P; Guaman CS; Metcalf XL; Lee V; Zaratzian A; Da Silva A; Tayao M; Rolo S; Phimmachanh M; Sultani G; McDonald L; Mason SM; Ferrari N; Ooms LM; Johnsson AE; Spence HJ; Olson MF; Machesky LM; Sansom OJ; Morton JP; Mitchell CA; Samuel MS; Croucher DR; Welch HCE; Blyth K; Caldon CE; Herrmann D; Anderson KI; Timpson P; Nobis M
Cell Rep; 2021 Sep; 36(11):109689. PubMed ID: 34525350
[TBL] [Abstract] [Full Text] [Related]
17. Cytoplasmic P120ctn Promotes Gefitinib Resistance in lung cancer Cells by Activating PAK1 and ERK Pathway.
Liu WW; Hu J; Wang R; Han Q; Liu Y; Wang S
Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):750-758. PubMed ID: 34412070
[TBL] [Abstract] [Full Text] [Related]
18. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
[No Abstract] [Full Text] [Related]
19. 22-O-(N-Boc-L-glycine) ester of renieramycin M inhibits migratory activity and suppresses epithelial-mesenchymal transition in human lung cancer cells.
Oo Y; Nealiga JQL; Suwanborirux K; Chamni S; Ecoy GAU; Pongrakhananon V; Chanvorachote P; Chaotham C
J Nat Med; 2021 Sep; 75(4):949-966. PubMed ID: 34287745
[TBL] [Abstract] [Full Text] [Related]
20. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/rac1 signalling axis in osteoclasts.
Ni J; Zhang X; Li J; Zheng Z; Zhang J; Zhao W; Liu L
Cell Death Dis; 2021 Jul; 12(7):662. PubMed ID: 34215717
[TBL] [Abstract] [Full Text] [Related]
[Next]
